Atatürk Üniversitesi Atatürk Üniversitesi
Ara
Yayınlara dön
Makale Tam Makale Uluslararası 2016

Should Low-Molecular-Weight Heparin be Preferred Over Unfractionated Heparin After Thrombolysis for Severity Pulmonary Embolism?

Aysegul Senturk, Elif Yılmazel Uçar, SERDAR BERK, TEVFİK ÖZLÜ, Bulent Altinsoy, Gul Dabak, Ebru Cakir, Esra Ekbic Kadioglu, HADİCE SELİMOĞLU ŞEN, Savas Ozsu

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS Cilt 22 · Sayı 4 · ss. 395–399 · 01.05.2016
DOI ile aç

Özet

Purpose: The role of low-molecular-weight heparin (LMWH) in managing nonmassive pulmonary embolism (PE) is well known. In unstable cases, especially after thrombolytic therapy for massive PE, unfractionated heparin (UFH) is preferred for PE management. This study aimed to investigate the effectiveness and safety of LMWH after thrombolytic therapy.

Atıf için künye

Senturk, A., Yılmazel Uçar, E., BERK, S., ÖZLÜ, T., Altinsoy, B., Dabak, G., Cakir, E., Kadioglu, E. E., ŞEN, H. S., & Ozsu, S. (2016). Should Low-Molecular-Weight Heparin be Preferred Over Unfractionated Heparin After Thrombolysis for Severity Pulmonary Embolism? CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 22(4), 395–399. https://doi.org/10.1177/1076029614564863

BibTeX 
@article{senturk2016-227142,
  author = {Senturk, Aysegul and Yılmazel Uçar, Elif and BERK, SERDAR and ÖZLÜ, TEVFİK and Altinsoy, Bulent and Dabak, Gul and Cakir, Ebru and Kadioglu, Esra Ekbic and ŞEN, HADİCE SELİMOĞLU and Ozsu, Savas},
  title = {Should Low-Molecular-Weight Heparin be Preferred Over Unfractionated Heparin After Thrombolysis for Severity Pulmonary Embolism?},
  journal = {CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS},
  year = {2016},
  volume = {22},
  number = {4},
  pages = {395--399},
  issn = {1076-0296},
  doi = {10.1177/1076029614564863},
  url = {https://akademik.atauni.edu.tr/yayinlar/227142-should-low-molecular-weight-heparin-be-preferred-over-unfractionated-heparin}
}